Hutch News

Hutch News

Stories tagged 'androgen receptor'

Targeted therapies push metastatic prostate cancer in new directions

Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments

Nov. 14, 2017 | By Sabrina Richards / Fred Hutch News Service

Dr. Pete Nelson and colleagues found that as hormone-targeting treatments grow more potent, recurrent prostate tumors are more often finding a new way around the drugs.

View story >

Tailoring treatment for prostate cancer

Hutchinson Center researchers and Duke University colleagues discover a genomic signature that may allow doctors to individualize therapy for men with metastatic prostate cancer

March 23, 2009

Fred Hutchinson Cancer Research Center researchers Drs. Elahe Mostaghel and Peter Nelson and colleagues at Duke University’s Institute for Genome Sciences & Policy authored a paper announcing the discovery of a genomic signature that may ultimately allow doctors to individualize therapy for men with aggressive prostate cancer that has metastasized to other organs.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.